3 results
Approved WMORecruiting
To assess whether lacosamide is as efficient in the treatment of chemotherapy-induced neuropathic pain as duloxetine
Approved WMORecruiting
ThThe primary efficacy objective is to determine whether a low-dose regimen of apixaban (2.5 mg bid) is non-inferior to a full-dose regimen of apixaban (5 mg bid) for the prevention of recurrent VTE in patients with cancer who have completed at…
Approved WMOCompleted
The objective of the study is to quantify the effect of pregabaline and lacosamide on oxycodone-induced respiratory depression.